How do citizens keep themselves informed about the most controversial scientific issues? Which sources of information do they choose? A two-year project aims to answer these questions in order to obtain valuable information on communication to the public, to be taken into account for the near future.

We speak with Prof. Donald Milton, Professor of Environmental Health, Applied Environmental Health (MIAEH), about the differences between SARS-CoV-1 and SARS-CoV-2.     Taking the precautionary principle in medicine into consideration, in your opinion why does the WHO insist on its statement regarding...

Rapid and open sharing of data greatly accelerates research and discovery, which is essential to respond to the COVID-19 pandemic. The European Commission and EMBL’s European Bioinformatics Institute (EMBL-EBI), together with EU Member States and research partners such as ELIXIR, are deploying a dedicated...

We speak with Dr. Marc Wathelet, Molecular Biologist, Coronavirus specialist, about the differences between SARS-CoV-1 and SARS-CoV-2     Taking your early, alarming statements and the precautionary principle in medicine into consideration, in your opinion why does the WHO insist on its statement on...

The current Covid-19 pandemic draws attention to the need to integrate health equity into urban planning. It encourages behaviours that both protect the environment and promote health.

We speak with Andrea Renda, professor of Digital Innovation at the College of Europe in Bruges (Belgium). He is a Senior Research Fellow and Head of the CEPS Unit on Global Governance, Regulation, Innovation and the Digital Economy (GRID).     How do you evaluate the current increased use of data (especially...

We speak with Innocenzo Genna, independent public affairs consultant advising in telecoms and Internet European regulation. He is also known via his professional blog RadioBruxellesLibera.     How would you evaluate the current increased use of data (especially in non-EU countries) and its effectiveness...

Since the unprecedented outbreak of the COVID-19 virus, the use of data has extensively been discussed. What obstacles do scientists, public health officials and private companies face when processing datasets? And how much digital privacy can EU citizens afford in times of crisis?